AAAAAA

   
Results: 1-15 |
Results: 15
WHO IS RIGHT - OR, HOW TO JUDGE THE DISAGREEMENT ABOUT HLA RESTRICTION OF NEF PEPTIDES - COMMENT
Authors: BRANDER C WALKER BD KORBER B
Citation: C. Brander et al., WHO IS RIGHT - OR, HOW TO JUDGE THE DISAGREEMENT ABOUT HLA RESTRICTION OF NEF PEPTIDES - COMMENT, AIDS research and human retroviruses, 14(11), 1998, pp. 923-924
LACK OF STRONG IMMUNE SELECTION PRESSURE BY THE IMMUNODOMINANT, HLA-A(ASTERISK)0201-RESTRICTED CYTOTOXIC T-LYMPHOCYTE RESPONSE IN CHRONIC HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
Authors: BRANDER C HARTMAN KE TROCHA AK JONES NG JOHNSON RP KORBER B WENTWORTH P BUCHBINDER SP WOLINSKY S WALKER BD KALAMS SA
Citation: C. Brander et al., LACK OF STRONG IMMUNE SELECTION PRESSURE BY THE IMMUNODOMINANT, HLA-A(ASTERISK)0201-RESTRICTED CYTOTOXIC T-LYMPHOCYTE RESPONSE IN CHRONIC HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION, The Journal of clinical investigation, 101(11), 1998, pp. 2559-2566
STIMULATION OF HUMAN CYTOTOXIC T-CELLS WITH HIV-1-DERIVED PEPTIDES PRESENTED BY RECOMBINANT HLA-A2 PEPTIDE COMPLEXES
Authors: WALTER JB BRANDER C MAMMEN M GARBOCZI DN KALAMS SA WHITESIDES GM WALKER BD EISEN HN
Citation: Jb. Walter et al., STIMULATION OF HUMAN CYTOTOXIC T-CELLS WITH HIV-1-DERIVED PEPTIDES PRESENTED BY RECOMBINANT HLA-A2 PEPTIDE COMPLEXES, International immunology, 9(3), 1997, pp. 451-459
CHARACTERIZATION OF LIDOCAINE-SPECIFIC T-CELLS
Authors: ZANNI MP MAURIHELLWEG D BRANDER C WENDLAND T SCHNYDER B FREI E VONGREYERZ S BIRCHER A PICHLER WJ
Citation: Mp. Zanni et al., CHARACTERIZATION OF LIDOCAINE-SPECIFIC T-CELLS, The Journal of immunology, 158(3), 1997, pp. 1139-1148
T-CELL REACTIONS IN PATIENTS SHOWING ADVERSE IMMUNE-REACTIONS TO DRUGS
Authors: ZANNI MP VONGREYERZ S SCHNYDER B MAURIHELLWEG D BRANDER C KALBERMATTEN C PICHLER WJ
Citation: Mp. Zanni et al., T-CELL REACTIONS IN PATIENTS SHOWING ADVERSE IMMUNE-REACTIONS TO DRUGS, Inflammation research, 45, 1996, pp. 79-84
CONTACT-DERMATITIS TO LOCAL-ANESTHETICS (LA) - IN-VITRO AND IN-VIVO CROSS-REACTIVITY
Authors: PICHLER WJ ZANNI MP MAURIHELLWEG D WENDLAND T BIRCHER A BRANDER C
Citation: Wj. Pichler et al., CONTACT-DERMATITIS TO LOCAL-ANESTHETICS (LA) - IN-VITRO AND IN-VIVO CROSS-REACTIVITY, The FASEB journal, 10(6), 1996, pp. 2769-2769
T-CELL REACTIVITY TO LIDOCAINE - EVIDENCE FOR OLIGOCLONAL EXPANSION AND SPECIFIC STIMULATION OF CD4-DELTA T-CELLS(, CD8+ AND GAMMA)
Authors: ZANNI MP MAURIHELLWEG D BRANDER C WENDLAND T BIRCHER A PICHLER WJ
Citation: Mp. Zanni et al., T-CELL REACTIVITY TO LIDOCAINE - EVIDENCE FOR OLIGOCLONAL EXPANSION AND SPECIFIC STIMULATION OF CD4-DELTA T-CELLS(, CD8+ AND GAMMA), The FASEB journal, 10(6), 1996, pp. 2770-2770
CROSS-REACTIVITY OF T-CELL LINES AND CLONES TO BETA-LACTAM ANTIBIOTICS
Authors: MAURIHELLWEG D ZANNI M FREI E BETTENS F BRANDER C MAURI D PADOVAN E WELTZIEN HU PICHLER WJ
Citation: D. Maurihellweg et al., CROSS-REACTIVITY OF T-CELL LINES AND CLONES TO BETA-LACTAM ANTIBIOTICS, The Journal of immunology, 157(3), 1996, pp. 1071-1079
PEPTIDE IMMUNIZATION IN HUMANS - A COMBINED CD8(+) CD4(+) T-CELL-TARGETED VACCINE RESTIMULATES THE MEMORY CD4 T-CELL RESPONSE BUT FAILS TO INDUCE CYTOTOXIC T-LYMPHOCYTES (CTL)/
Authors: BRANDER C CORRADIN G HASLER T PICHLER WJ
Citation: C. Brander et al., PEPTIDE IMMUNIZATION IN HUMANS - A COMBINED CD8(+) CD4(+) T-CELL-TARGETED VACCINE RESTIMULATES THE MEMORY CD4 T-CELL RESPONSE BUT FAILS TO INDUCE CYTOTOXIC T-LYMPHOCYTES (CTL)/, Clinical and experimental immunology, 105(1), 1996, pp. 18-25
T-CELL REACTIVITY TO DRUGS
Authors: PICHLER WJ MAURI DH BRANDER C
Citation: Wj. Pichler et al., T-CELL REACTIVITY TO DRUGS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 172-172
HETEROGENEOUS T-CELL RESPONSES TO BETA-LACTAM-MODIFIED SELF-STRUCTURES ARE OBSERVED IN PENICILLIN-ALLERGIC INDIVIDUALS
Authors: BRANDER C MAURIHELLWEG D BETTENS F ROLLI H GOLDMAN M PICHLER WJ
Citation: C. Brander et al., HETEROGENEOUS T-CELL RESPONSES TO BETA-LACTAM-MODIFIED SELF-STRUCTURES ARE OBSERVED IN PENICILLIN-ALLERGIC INDIVIDUALS, The Journal of immunology, 155(5), 1995, pp. 2670-2678
ACTIVATION OF DRUG-SPECIFIC CD4(-CELLS IN INDIVIDUALS ALLERGIC TO SULFONAMIDES, PHENYTOIN, AND CARBAMAZEPINE() AND CD8(+) T)
Authors: MAURIHELLWEG D BETTENS F MAURI D BRANDER C HUNZIKER T PICHLER WJ
Citation: D. Maurihellweg et al., ACTIVATION OF DRUG-SPECIFIC CD4(-CELLS IN INDIVIDUALS ALLERGIC TO SULFONAMIDES, PHENYTOIN, AND CARBAMAZEPINE() AND CD8(+) T), The Journal of immunology, 155(1), 1995, pp. 462-472
IDENTIFICATION OF HIV PROTEIN-DERIVED CYTOTOXIC T-LYMPHOCYTE (CTL) EPITOPES FOR THEIR POSSIBLE USE AS SYNTHETIC VACCINE
Authors: BRANDER C PICHLER WJ CORRADIN G
Citation: C. Brander et al., IDENTIFICATION OF HIV PROTEIN-DERIVED CYTOTOXIC T-LYMPHOCYTE (CTL) EPITOPES FOR THEIR POSSIBLE USE AS SYNTHETIC VACCINE, Clinical and experimental immunology, 101(1), 1995, pp. 107-113
IMPROVED SENSITIZATION OF ANTIGEN-PRESENTING CELLS WITH TRANSFERRIN-BOUND PEPTIDES - ADVANTAGES IN COMPETITION FOR ANTIGEN PRESENTATION
Authors: MAURI D WYSSCORAY T BRANDER C PICHLER WJ
Citation: D. Mauri et al., IMPROVED SENSITIZATION OF ANTIGEN-PRESENTING CELLS WITH TRANSFERRIN-BOUND PEPTIDES - ADVANTAGES IN COMPETITION FOR ANTIGEN PRESENTATION, Cellular immunology, 158(1), 1994, pp. 59-70
CARRIER-MEDIATED UPTAKE AND PRESENTATION OF A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED PEPTIDE
Authors: BRANDER C WYSSCORAY T MAURI D BETTENS F PICHLER WJ
Citation: C. Brander et al., CARRIER-MEDIATED UPTAKE AND PRESENTATION OF A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED PEPTIDE, European Journal of Immunology, 23(12), 1993, pp. 3217-3223
Risultati: 1-15 |